期刊文献+

人腺苷激酶在大肠杆菌中的表达与纯化

Prokaryotic Expression and Purification of Human Adenosine Kinase
原文传递
导出
摘要 目的诱导人腺苷激酶重组蛋白在大肠杆菌中表达,并对表达的重组蛋白进行纯化。方法将由人腺苷激酶基因开放阅读框与原核表达载体pET30a(+)连接构建的重组蛋白表达载体pET30a(+)/ADK转化大肠杆菌表达菌株BL21(DE3)感受态细胞。1mmol/L的IPTG诱导重组蛋白表达。离心收集菌体后结合使用溶菌酶、冻融和超声破碎的方法裂解菌体。用含2mol/L和4mol/L尿素的结合缓冲液洗涤包涵体去除部分杂蛋白。随后用含8mol/L尿素的结合缓冲液变性溶解剩余包涵体沉淀。用Ni-NTA柱通过亲和层析纯化重组蛋白,用含8mol/L尿素的洗脱缓冲液洗脱,收集样品透析复性。结果成功构建人腺苷激酶原核表达载体且目的蛋白以包涵体形式表达。经包涵体洗涤、变性溶解,亲和层析及分步透析复性获得纯度达85%以上的重组蛋白。结论人腺苷激酶表达载体的成功构建以及重组蛋白的纯化,为进一步进行其结构和功能的研究奠定了基础。 Objective To induce human adenosine kiuase recombinant protein expression in E.coli and purify the recombinant protein. Methods The human adenosine kinase recombinant protein expression vector pET30a(+)/ ADK was constructed by connecting the ORF of human adenosine kinase gene and prokaryotic expression vector pET30a(+ ). The recombinant vector was transformed into E.coli BL21 (DE3). The recombinant protein was induced by adding IPTG in culture medium to 1 mmol/L. The cell pellet were lysed by the combined use of sonication and lysozyme. The pellet of inclusion bodies was washed with binding buffer which containing 2 mol/L and 4 mol/L urea and dissolved with binding buffer containing 8 mol/L urea. The supernatant was used for affinity chromatography using Ni-NTA column, The recombinant protein sample was obtained by eluted Ni-NTA column with elution buffer which containing 8 mol/L urea. SDS-PAGE gel eleetrophoresis was carried out to analyze the specificity of recombinant protein. Results Human adenosine kinase recombinant protein expression vector was successfully constructed by seamless cloning method. The recombinant protein was expressed as inclusion bodies and its molecular weight was about 46 kDa, consistent with the expecting value. Through affinity chromatography recombinant protein was purified and the purity coefficient was up to 85%. Conclusion Highly purified human adenosine kinase recombinant protein was obtained and can be used directly to prepare antibody and may facilitate further protein role and structure investigation.
出处 《热带医学杂志》 CAS 2010年第1期34-36,44,共4页 Journal of Tropical Medicine
基金 国家高技术研究发展计划(863)(No.2006AA02A311)
关键词 腺苷激酶 表达 纯化 包涵体 复性 human adenosine kinase expression purification inclusion body refolding
  • 相关文献

参考文献14

  • 1Colowick SP, Kalckar HM. The role of myokinase in ransphosphorylations. I. The enzymatic phosphorylation of hexoses by adenylpyrophosphate [J]. J Biol Chem, 1943,148:117-126.
  • 2Kalckar HM. Adenylpyrophosphatase and myokinase [J]. J Biol Chem, 1944,153 : 355-367.
  • 3Biaggioni I, Killian TJ, Mosqueda-Garcia R, et al. Adenosine increases sympathetic nerve traffic in humans [J]. Circulation, 1991,83 : 1668-1675.
  • 4Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity [J]. Trends Immunol, 2004,25 : 33-39.
  • 5Cronstein BN. Adenosine, an endogenous anti-inflammatory agent [J]. J Appl Physiol, 1994,76:5-13.
  • 6Abrusci P, Chiarelli LR, Galizzi A, et al. Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia [J]. Exp Hematol, 2007,35:1182-1189.
  • 7Corrons JL, Garcia E, Tusell JJ, et al. Red cell adenylate kinase deficiency: molecular study of 3 new mutations (IISG>A, 190G>A, and GAC deletion) associated with hereditary nonspherocytic hemolytic anemia [J]. Blood, 2003,102 : 353-356.
  • 8Toren A, Brok-Simoni F, Ben-Bassat I, et al. Congenital haemolytic anaemia associated with adenylate kinase deficiency [J]. Br J Haematol, 1994,87 : 376-380.
  • 9Jackson RC, Morris HP, Weber G. Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumours [J]. Br J Cancer, 1978,37 : 701-713.
  • 10Ge Y, Molloy MP, Chamberlain JS, et al. Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity [ J ]. Proteomics, 2003,3 : 1895-1903.

二级参考文献26

  • 1[1]Single B, Leist M, Nicotera P. Simultaneous release of adenylate kinase and cytochrome c in cell death. Cell Death Differ, 1998,5:1001~1003
  • 2[2]Kohler C, Gahm A, Noma T, et al. Release of adenylate kinase from the mitochondrial intermembrane space during apoptosis. FEBS Lett,1999,447(1):10~12
  • 3[3]Kluck R M, Esposti M D, Perking G, et al. The pro-apoptotic proteins,Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol. J Cell Biol,1999,147(4):809~822
  • 4[4]Stridh H, Fava E, Single B, et al. Tributyltin-induced apoptosis requires glycolytic adenosine trisphosphate production. Chem Res Toxicol,1999,12(10):874~882
  • 5[5]Inouye S, Yamada Y, Miura K, et al. Distribution and developmental changes and adenylate kinase isozymes in the rat brain:localization of adenylate kinase 1 in the olfactory bulb. Biochem Biophys Res Commun, 1999,254:618~622
  • 6Fredholm BB, Chen JF, Cunha RA, et al. Adenosine and brain function. Int. Rev. Neurobiol, 2005, 63 ( 1 ) : 191-270.
  • 7Kowaluk EA, Jarvis MF. Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs, 2000, 9 (3) : 551-564.
  • 8Cunha RA. Neurepretection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal, 2005, 1(2): 111-134.
  • 9Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discv, 2006, 5(3) : 247 -264.
  • 10Pawelczyk T, Sakowicz M, Podgorska M, et al. Insulin induces expression of adenosine kinase gene in rat lymphocytes by:signaling through the mitogen-activated protein kinase path way. Exp Cell Res, 2003, 286(2) : 152-163.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部